EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing Risk Thresholds in Controlled Human Infection Models (CHIM)

Alexa Nord-Bronzyk iD, Barnaby Young, Jerry Menikoff iD, Julian Savulescu iD, G Owen Schaefer

Bioethics · 2026-06 · 40 (5) · 519-529

DOI: 10.1111/bioe.70072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioethics, online erschienen am 24.03.2026. Verfasst von Alexa Nord-Bronzyk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singpaore, Singapore. Hauptthemen laut MEDLINE: Human Challenge Trials as Topic. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Controlled Human Infection Models (CHIMs) are a type of clinical trial involving deliberately exposing human volunteers to an infectious agent. Compared to studies of natural infection, CHIMs offers distinctive benefits, from the ability to study presymptomatic infection to a direct assessment of the efficacy of vaccines and therapeutics in a shorter time and involving fewer participants. Although the CHIMs do not fundamentally differ from other early‐phase clinical trials, they raise a unique set of ethical considerations. Modern CHIMs have been limited to studies which pose very low risk of participants experiencing serious adverse events, and CHIMs which lie on the upper end of risk remain controversial. Setting risk thresholds for more hazardous trials has become a topic of debate leading to various attempts to develop a model to ethically evaluate these risks. While there are now well‐accepted practices around established pathogens, future pandemics may involve more extreme threats to public health and CHIMs may have an important emergency rescue function, with some groups willing to undertake significant risks. We must ask, what risk of death and serious morbidity should future CHIMs permit in the face of such challenges? This paper proposes a taxonomy laying out three possible approaches for thinking about risk thresholds in CHIM: (1) consistency; (2) engaging community perspectives; and (3) no risk threshold. We explore the strengths and weaknesses of each approach and offer a resource for those in the research community to inform their evaluation of the ethical permissibility of current and future CHIM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Challenge Trials as TopicHumansRisk Assessment

Stichwörter der Autor:innen

challenge trialsresearch ethicsrisk thresholdsrisk‐benefit assessments

Autor:innen und Institutionen

  • Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singpaore, Singapore.
  • National Centre for Infectious Diseases; Department of Infectious Diseases, Tan Tock Seng Hospital; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Uehiro Oxford Institute, University of Oxford, Oxford, UK.

ORCID-Profile: Alexa Nord-Bronzyk, Jerry Menikoff, Julian Savulescu

Zitieren

APA

Nord-Bronzyk, A., Young, B., Menikoff, J., Savulescu, J., & Owen Schaefer, G. (2026). Assessing Risk Thresholds in Controlled Human Infection Models (CHIM). Bioethics, 40(5), 519-529. https://doi.org/10.1111/bioe.70072

Vancouver

Nord-Bronzyk A, Young B, Menikoff J, Savulescu J, Owen Schaefer G. Assessing Risk Thresholds in Controlled Human Infection Models (CHIM). Bioethics. 2026;40(5):519-529. doi:10.1111/bioe.70072

BibTeX
@article{NordBronzyk2026,
  author = {Nord-Bronzyk, Alexa and Young, Barnaby and Menikoff, Jerry and Savulescu, Julian and Owen Schaefer, G},
  title = {Assessing Risk Thresholds in Controlled Human Infection Models (CHIM)},
  journal = {Bioethics},
  year = {2026},
  volume = {40},
  number = {5},
  pages = {519--529},
  doi = {10.1111/bioe.70072}
}
Kostenlos starten →